Key Takeaways
- Plaza Feed & Crop Nutrition has signed an exclusive agreement with Intralytix to develop bacteriophage-based kits for protein live production.
- The kits combine Intralytix’s targeted bacteriophages with Plaza’s Cecabiotics probiotic to manage pathogens while supporting beneficial microbiota.
- The solution targets key foodborne pathogens, including E. coli, Salmonella, and Listeria.
- The combined approach is designed to support poultry, ruminant, and other livestock systems.
- Plaza and Intralytix plan to engage with industry stakeholders at IPPE 2026.
Plaza Feed & Crop Nutrition Expands Biosolutions Portfolio Through Intralytix Agreement
Plaza Feed & Crop Nutrition announced an exclusive agreement with Intralytix to use the company’s bacteriophage technology in newly developed phage kits for protein live production applications. The agreement brings together two complementary biological approaches aimed at improving pathogen control and microbiome balance in livestock systems.
Under the agreement, Plaza will incorporate Intralytix’s bacteriophages—highly specific antimicrobials designed to target defined pathogenic serotypes—into kits that also include Plaza’s Cecabiotics probiotic platform. The combined solution is intended for use across poultry, ruminants, and other livestock production systems.
How Plaza Feed & Crop Nutrition Combines Phages and Probiotics
Targeted Pathogen Control with Microbiome Support
Intralytix’s bacteriophages are grouped into combinations that target common pathogens such as E. coli, Salmonella, and Listeria. These phages rapidly attack and reduce harmful bacteria. Cecabiotics, Plaza’s wide-spectrum probiotic, is then designed to occupy the ecological space left behind, limiting pathogen regrowth through competitive exclusion while supporting nutrient optimization and animal performance.
